Latest MedImmune Stories
MERIDEN, Conn., May 13, 2015 /PRNewswire/ -- Protein Sciences Corporation announced that on May 12, 2015 the U.S.
-- Initiated Phase 2 for Prevention of C.
GAITHERSBURG, Md., April 22, 2015 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) today announced that the Board of Directors of GenVec, Inc.
OXFORD, England, April 16, 2015 /PRNewswire/ -- Immunocore Limited, a world-leading biotechnology company developing novel biological drugs to treat cancer and other diseases,
SHANGHAI, March 27, 2015 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc.
-- Steady Progress in All Programs; Two Phase 2 Clinical Trials to Start in 2015 -- ROCKVILLE, Md., March 16, 2015 /PRNewswire/ --
GAITHERSBURG, Md., March 2, 2015 /PRNewswire/ -- VLP Therapeutics, LLC.
MERIDEN, Conn., Feb.
University of Maryland researchers are covering soap bubbles with biomaterials that act as a disguise, tricking the body’s cells into mistaking the capsule for a bacterium, a cancer cell or
NORWALK, Conn., Jan.
- A handkerchief.
- In general, any miraculous portrait of Christ.